New-onset refractory status epilepticus (NORSE) is a rare, potentially devastating condition that occurs abruptly in previously healthy patients of any age but most commonly in children and young adults. It has an unpredictable clinical course requiring immediate, often prolonged, critical care support with multiple specialists involved and frequently results in severe life-altering sequelae or death. Communication in NORSE is challenging because its etiology in a given patient is initially unknown (and often remains so), the clinical course and outcome are unpredictable, and many health care team members are involved in the care of a patient. We address the communication challenges seen in NORSE through proactive communication on 3 levels: (1) in the shared decision-making process with the family, (2) within an individual hospital, and (3) across institutions. Intentional organizational change and enhanced information dissemination may help break down barriers to effective communication. Key initiatives for enhancing information dissemination in NORSE are (1) the identification of a most responsible physician to integrate information from subspecialties, to communicate frequently and candidly with the family, and to provide continuity of care over a prolonged period of time and (2) the early involvement of palliative care services alongside ongoing therapies with curative intent to support families and the medical team in decision making and communication.
patients were more likely to receive immunotherapy and to have better outcomes than in those cases that remained cryptogenic. 3 It is not clear if the better outcomes were related to differences in etiology or differences in treatment. Mortality was 22% with poor outcome in more than half. Virtually all survivors continued taking antiseizure medication. 3 Communication in NORSE is complicated because there are many unknowns. The newly proposed definition 1 integrates 2 disorders, NORSE 4 and FIRES (febrile illness-related epilepsy syndrome), 5 which previously had been considered potentially distinct entities in adults and children. The new definition combines the adult and pediatric populations and the experience of 2 different fields of medicine. Additionally, NORSE is a clinical syndrome. 4 Some scientists are reluctant to use a definition that does not specify an etiology at onset and, indeed, cites the lack of an etiology as a distinguishing characteristic.
Caring for patients with NORSE is complex and requires the integration of expertise from multiple medical services. Establishing and maintaining adequate communication and agreement on the most appropriate care plan with the involvement of multiple specialists over weeks to months can be challenging, especially given that different specialties may have different cultures of communication and varying rotating coverage in a tertiary care center.
The physicians caring for a patient with NORSE often never actually get to meet their patient while conscious or have the opportunity to communicate directly with their patient. Physicians must identify and confer with patient surrogates or substitute decision makers (SDMs). Communication is further complicated by the precipitous nature of the disorder and its short time frame for treatment. The patient's goals for treatment can only be inferred by the SDM, who is often shocked by the sudden onset of illness. Public awareness of NORSE is virtually nonexistent, and family members are asked to make critical medical decisions involving a disorder previously unknown to them.
NORSE presents a "perfect storm" for poor communication. It strikes without warning in previously healthy individuals, frequently children and young adults who do not have advanced directives and for whom palliative care is not typically considered. The shared decision-making process relies on families/ SDMs with no previous knowledge of NORSE who must make treatment decisions despite a lack of established treatment protocols or a predictable prognosis.
We propose to address these communication challenges through proactive communication at 3 levels: (1) in the shared decisionmaking process with the family, (2) within an individual hospital, and (3) Caring for patients with NORSE requires intensive daily managementdfrequently for weeks to months. The health care team often becomes deeply involved with their patients and their families through these frequent interactions. Individual members of the medical teams may have differing knowledge of the disorder and differing views on treatment goals, including when to stop or withhold treatment. The standard approach is to be very aggressive initially and, when all treatments have failed, to transition the goals of care from prolonging life to ensuring comfort while allowing for a natural death, depending on the patient's values and best interest. The optimal timing of this transition is unknown and varies from patient to patient.
The shock, grief, anger, and denial that may accompany the diagnosis of any dire medical condition like cancer, traumatic brain injury, or stroke are amplified in NORSE because there are no preceding symptoms as there are in cancer and no known triggering event as there is in traumatic brain injury. There is no familiar cause of death or disability like, for example, stroke. NORSE strikes suddenly in healthy people, and most people, including some medical professionals, have never heard of it before. The situation takes on a surreal aspect for the family, which makes it difficult for them to process information and identify goals of treatment.
Despite all the unknowns in NORSE, doctors do know that it is rare to survive the disorder unscathed and recognize the high probability of death. When patients do emerge from coma, they face multiple complex challenges on physical, cognitive, and emotional levels. 9 Deciding whether further treatment is in the best interest of the patient requires full and candid information with effective shared decision making. [10] [11] [12] Uncertainty is inherent to NORSE, and openly discussing the uncertainty may enhance trust between the family and the health care team. The conversation can begin by providing the family/SDM with a clinical presentation of NORSE, which provides an important point of reference.
There are various published models available to guide the health care team through the process of breaking bad news. 7,13,14 Common elements of these models include choosing an A palliative approach to care is defined as an approach to care that focuses on quality of life in individuals and their families facing life-threatening illness. It aims to prevent and relieve suffering through early identification, assessment, and treatment of pain and other problemsdphysical, psychosocial, and spiritual.
appropriate setting for information sharing; ensuring that the appropriate people are present both on the part of the health care team and the patient-family unit to ascertain the patient's/family's understanding of their illness and desire for further information; providing accurate information regarding diagnosis, treatment, and prognosis in appropriate lay terms; acknowledging the patient's emotions and response to information; eliciting information regarding the patient's values and preferences for care; and allowing time for further questions from the patient and family. 7,13,14 Regular discussions with the family about prognosis and expected outcomes, while addressing the uncertainties head on, are necessary. Ideally these discussions should occur in a multidisciplinary fashion, and when this is not feasible, all communication should be directed through the most responsible physician.
As in the case of any complex, lifethreatening illness, palliative medicine expertise should be incorporated early alongside ongoing, aggressive therapies with curative intent. A palliative approach to care incorporates a focus on quality of life in individuals and their families facing life-threatening illness of any kind. It is distinct from hospice care (which is limited to the last 6 months of life in the United States) and provides supportive care and symptom management alongside curative therapies early in the disease trajectory. It need not be reserved for the final days or weeks of life. Throughout the disease trajectory, it aims to prevent and relieve suffering through early identification, assessment, and treatment of pain and other problemsdphysical, psychosocial, and spiritual. 15 A palliative approach to care includes aggressive symptom management, effective and purposeful communication, and support for the family and the health care team. If it becomes necessary to transition the care plan from one of curative intent to comfortfocused care, the transition may be eased if families are already familiar with the palliative care team. This helps the family to avoid a feeling of abandonment when the primary care team and the care plan change. In the absence of a palliative care consulting service, a palliative approach to care can be incorporated by the primary care team (Table 2) . 10, 16 Communication Among Medical Teams Awareness of NORSE is uneven across disciplines within the hospital (Table 1 , Section 2). In some hospitals, the care may be divided into 2 parts: (1) the critical care team focusing on the body and (2) the neurology team focusing on the brain. Regardless of the institutional team approach to patient care, published guidelines for the management of status epilepticus should be shared among teams and used to support clinical decision making. Valuable references include an approach to the management of status epilepticus in the first hour 17 and more in-depth guidelines outlining the ongoing management of status epilepticus. 18, 19 Development of a NORSE education program could inform all relevant disciplines, especially the nursing team, which spends the most time at the patient's bedside. An education program should focus on the disease itself, the latest research, how treatments are chosen, and potential outcomes. 20 Such a program provides an opportunity to design a model of care outside of the immediate crisis environment of an active case of NORSE and raise awareness of this rare disorder.
Because the risk of morbidity and mortality is high and multiple medical specialties are involved, 21 a palliative approach should be part of the plan of care from the early stages of admission in order to integrate information and improve patient-centered decision making. Physicians often hesitate to consult palliative specialists because it may be considered an admission of failure or loss of hope. Although the involvement of palliative care can frighten families, who may believe the doctors have given up, the inclusion of palliative care expertise early in the disease course may facilitate medical decision making and communication with families. 8 Research has found that critically ill patients can benefit from palliative care in conditions of prognostic uncertainty, disagreement over goals of care, complex symptom management, and the need for additional support in decision making. 10, 22 All of these factors exist in patients with NORSE.
Communication Across Institutions and With the Public NORSE is uncommon and requires 24-hour electroencephalographic monitoring. Thus, not all medical centers have the required expertise to manage NORSE, making clinical experience with NORSE uneven across institutions and among professionals. This makes the widespread transmission of NORSErelated information of paramount importance (Table 1 , Section 3). Early interhospital transfer to an institution with the appropriate level of expertise, including neurocritical care and continuous electroencephalographic monitoring and for consideration of diseasespecific investigations and therapies (possible immunotherapy), is important in order to optimize care delivery and minimize complications. In general, interhospital critical care transfers occur in order to access specific investigations or for additional resources at the receiving hospital. 23 The dissemination of information across different fields of medicine, geographic locations, and practice settings should cast a wide net to include sources with the potential to contribute knowledge. 20, 24 Awareness and diagnosis of NORSE within and between institutions are required to build patient registries. A multicenter, prospective, observational study of patients with NORSE is currently under way through the Critical Care EEG Monitoring Research Consortium (https://www.acns.org/research/critical-careeeg-monitoring-research-consortium-ccemrc). Clinical data and biological specimens are being collected to allow for immunologic and genetic testing. In addition, an open, international family registry of NORSE patients with data provided by caregivers is being developed.
The term NORSE was first coined within the medical literature in 2005, 4 but there was no information about NORSE for the general public until 2015. Gaspard and Hirsch's report on NORSE for the National Organization of Rare Disorders, a public forum, first acknowledged NORSE outside of the health care community. 25 The gap between the health care community's and SDMs' knowledge of NORSE may be bridged by providing 
